Navigation » List of Schools » International College of Health Sciences » Nursing » Nursing 1141- Pharmacology » Fall 2022 » Mastery EAQ Ch. 26
Below are the questions for the exam with the choices of answers:
Question #1
A The medication will be stopped.
B The dose will be decreased.
C The dose will be increased.
D The dose will be unchanged.
Question #2
A Not a candidate for fondaparinux based on an insufficient creatinine clearance
B Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
C Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
D Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
Question #3
A Too low
B Too high
C Within normal limits
D Inadequate to evaluate treatment
Question #4
A Inadequate to evaluate treatment
B Significantly decreased
C Within normal limits
D Significantly elevated
Question #5
A Assess for dysrhythmias.
B Stop the medication if the systolic blood pressure drops below 110 mm Hg.
C Monitor liver enzymes.
D Administer prescribed vitamin K if bruising is observed.
Question #6
A Administering the medication intramuscularly in the vastus lateralis
B Massaging the site after the injection
C Administering the medication when convenient
D Checking if the patient’s prescription contains enoxaparin
Question #7
A “I refrain from drinking coffee and citrus fruit juices daily.”
B “I take ginkgo supplements for memory enhancement.”
C “I eat 1 cup of green leafy vegetables daily.”
D “I do not take aspirin for pain relief.”
Question #8
A “I avoid tight-fitting stockings or leggings.”
B “I get up and walk around at least once an hour.”
C “I never sit with my legs crossed at the knees.”
D “I’ve been on prolonged bed rest.”
Question #9
A Phytonadione
B Tranexamic acid
C Alteplase
D Aminocaproic acid
Question #10
A Carbamazepine
B Barbiturate
C Cimetidine
D Cholestyramine
Question #11
A Heart rate, Hemoglobin, Blood pressure
B Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
C Platelet count, Heart rate, Blood pressure
D Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
Question #12
A “I will place the pills in an organizer for easy use.”
B “I will use the medication within 60 days after it is opened.”
C “I will store the bottle in a dry place.”
D “I will take the medication with food.”
Question #13
A Loss of 10 pounds
B Platelet count of 80,000/mm3
C Diagnosis of diabetes mellitus
D Creatinine clearance of 25 mL/min
Question #14
A The dosage of the amiodarone will be increased by half.
B The dosage of the warfarin will be increased by half.
C The dosage of the amiodarone will be decreased by half.
D The dosage of the warfarin will be decreased by half.
Question #15
A Monitor the patient for decreased action of the anticoagulant.
B Instruct the patient to notify the nurse if he or she begins to experience discomfort.
C Continue to administer cimetidine with each dose of warfarin.
D Monitor the patient for increased action of the anticoagulant.
Question #16
A Peptic ulcer disease
B Severe chest pain for the past 2 hours
C Gastrointestinal bleed
D Local thrombosis from a peripheral intravenous line
Question #17
A Stop the medication.
B Notify the health care provider immediately.
C Monitor the patient and check the therapeutic range.
D Increase the dose of heparin.
Question #18
A Cannot be interpreted without knowing the prothrombin time and international normalized ratio
B Within the expected target therapeutic level of anticoagulation
C Outside the expected target therapeutic level of anticoagulation; it is too high
D Outside the expected target therapeutic level of anticoagulation; it is too low
Question #19
A Leukocyte count: 3000 cells/mm3
B Platelet count: 100,000/mm3
C Hemoglobin level: 11 g/dL
D Prothrombin time: 13 sec
Question #20
A Chronic obstructive pulmonary disease, Atrial fibrillation
B History of myocardial infarction, Chronic obstructive pulmonary disease
C Peptic ulcer disease, Chronic kidney disease
D Atrial fibrillation, History of myocardial infarction
Question #21
A International normalized ratio (INR) of 1
B Activated partial thromboplastin time (aPTT) of 37 seconds
C Platelet count of 95,000/mm3
D Potassium level of 3.5 mEq/L
Question #22
A Outside the expected target therapeutic level of anticoagulation; it is too low
B Within the expected target therapeutic level of anticoagulation
C Outside the expected target therapeutic level of anticoagulation; it is too high
D The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
Question #23
A “Refrigerate and keep away from direct sunlight.”
B “Discard the drug within 21 days of opening the original container.”
C “Store the drug with the desiccant-drying agent in the packing cap.”
D “Remove from the original package and place in aluminum foil.”
Question #24
A Ketoconazole
B Enoxaparin
C Amiodarone
D Furosemide
Question #25
A Monitor the patient’s laboratory values correctly.
B Teach the patient about dietary restrictions while on the medication.
C Ensure that a loading dose was initially administered when beginning
D Have protamine sulfate readily available at all times.
Question #26
A Administer protamine sulfate IV.
B Stop the intravenous (IV) drip.
C Wait for the INR to decrease.
D Administer vitamin K1 (phytonadione) IV.
Question #27
A Dissolution of the clot that caused the heart attack
B A quick decrease in pain
C Reversal of damage from the infarction
D Prevention of new clots from forming
Question #28
A “I should follow a low-cholesterol diet during the therapy.”
B “I should refrain from eating broccoli during the therapy.”
C “I should take oral contraceptives during the therapy.”
D “I should not use any acetaminophen during the therapy.”
Question #29
A “I should use a soft toothbrush for dental hygiene.”
B “I should keep taking ibuprofen for my arthritis.”
C “I will double my dose if I forget to take it the day before.”
D “I should decrease the dose if I start bruising easily.”
Question #30
A “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
B “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
C “There is no real difference; dalteparin is interchangeable with regular heparin.”
D “The only difference is that regular heparin dosing is based on the patient’s weight.”
Question #31
A Rub the administration site after injecting.
B Utilize the Z-track method to inject the medication.
C Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
D Administer the medication into subcutaneous tissue of the abdomen.
Question #32
A “I will increase dark green leafy vegetables in my diet.”
B “I will contact my health care provider if I develop excessive bruising.”
C “I will take my medication at the same time each day.”
D “I will avoid contact sports.”
Question #33
A Vitamin K
B Protamine sulfate
C Calcium gluconate
D Vitamin E
Question #34
A Recombinant factors
B Warfarin daily
C Aspirin daily (i.e., 81 mg)
D Vitamin K daily
Question #35
A Vitamin K deficiency
B Transient ischemic attack
C Acute unstable angina
D Peripheral vascular disease
Question #36
A Enoxaparin intramuscularly
B Warfarin orally
C Heparin subcutaneously
D Dabigatran orally
Question #37
A Ingestion of acetaminophen
B Over-the-counter medications
C Urine culture
D Platelet level
Question #38
A August 29
B September 15
C July 31
D October 1
Question #39
A Edema
B Itching
C Nausea
D Chest pain
Question #40
A Platelet count of 150,000 mm3
B Blood urea nitrogen (BUN) level of 12 mg/dL
C International normalized ratio (INR) of 1.0
D Activated partial thromboplastin time (aPTT) of 120 seconds
Question #41
A Fasting blood glucose level of 95 mg/dL
B Creatinine clearance value of 40 mL/min
C Hemoglobin level of 16.5 g/dL
D Platelet count of 75,000 cell/μL
Question #42
A Factor Xa
B Antithrombin III
C Vitamin K
D Thrombin
Question #43
A Aminocaproic acid
B Desmopressin
C Alteplase
D Tranexamic acid
Question #44
A Antiplatelet
B Thrombolytic
C Anticoagulant
D Antifibrinolytic
Question #45
A Heart failure
B Cardiomyopathy
C Acute myocardial infarction
D Coronary artery disease
Question #46
A Aspirin
B Dipyridamole
C Cilostazol
D Pentoxifylline
Question #47
A Dabigatran
B Fondaparinux
C Enoxaparin
D Argatroban
Question #48
A Selective factor Xa inhibitors
B Direct thrombin inhibitors
C Warfarin
D Heparins
Question #49
A Anticoagulants interfere with drug metabolism.
B Anticoagulants dissolve clots.
C Anticoagulants prevent clots from forming.
D Anticoagulants alter platelet function.
Question #50
A Anticoagulant
B Antifibrinolytic
C Antiplatelet
D Thrombolytic
Question #51
A Anxiety
B Embolus to the lungs
C Fatigue from walking with pain
D Medication reaction
Question #52
A Administering vitamin K1
B Increasing the dose of enoxaparin
C Infusing 50 mL of warfarin sodium
D Administering protamine sulfate
Question #53
A Potassium
B Calcium
C Aspirin
D Vitamin K